STAT3 and acute graft versus host disease: It may be that the lack of severe post-HSCT inflammatory complications including acute graft-versus-host disease, observed in these patients and the previously reported cases, might be due to reduced endothelial cell upregulation, conferred by dominant negative STAT3-LOF mutations.